What's Happening?
Jenny Slatten, known for her role on the reality TV show '90 Day Fiancé', has been diagnosed with Amyotrophic Lateral Sclerosis (ALS). In an interview, Slatten revealed that she began experiencing symptoms such as migraines, difficulty swallowing, and
slurred speech. Her husband, Sumit Singh, noted that a fan's suggestion to look into ALS led to the diagnosis. The couple recalled that Slatten's father had died from ALS complications a decade earlier. They are now considering genetic testing to explore ways to slow the disease's progression. Despite the diagnosis, Slatten expressed a desire to continue living life as usual and not be treated differently. The news comes as the couple prepares for their appearance on the upcoming season of '90 Day: The Last Resort', where they participate in a group therapy retreat.
Why It's Important?
ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. Slatten's diagnosis brings attention to the challenges faced by individuals with ALS and the importance of early detection and research into treatment options. The public nature of her diagnosis may increase awareness and support for ALS research and advocacy. For fans of '90 Day Fiancé', this development adds a personal and emotional dimension to Slatten's story, potentially influencing public perception and engagement with the show. The couple's decision to continue participating in the show despite the diagnosis highlights their resilience and commitment to raising awareness about the condition.
What's Next?
Slatten and Singh are exploring genetic testing to understand the potential hereditary nature of ALS in Slatten's case. This could provide insights into managing the disease and inform future medical decisions. As they continue to participate in '90 Day: The Last Resort', their journey may be documented, offering viewers a deeper understanding of living with ALS. The show's platform could serve as a vehicle for raising awareness and fostering discussions about ALS, potentially influencing public support for research and funding.
